ATE541919T1 - Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält - Google Patents

Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält

Info

Publication number
ATE541919T1
ATE541919T1 AT06708017T AT06708017T ATE541919T1 AT E541919 T1 ATE541919 T1 AT E541919T1 AT 06708017 T AT06708017 T AT 06708017T AT 06708017 T AT06708017 T AT 06708017T AT E541919 T1 ATE541919 T1 AT E541919T1
Authority
AT
Austria
Prior art keywords
cell culture
protein
serum
cells
production
Prior art date
Application number
AT06708017T
Other languages
English (en)
Inventor
Ida Knudsen
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36607297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE541919(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE541919T1 publication Critical patent/ATE541919T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06708017T 2005-02-11 2006-02-06 Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält ATE541919T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500204 2005-02-11
PCT/EP2006/050669 WO2006084826A1 (en) 2005-02-11 2006-02-06 Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate

Publications (1)

Publication Number Publication Date
ATE541919T1 true ATE541919T1 (de) 2012-02-15

Family

ID=36607297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06708017T ATE541919T1 (de) 2005-02-11 2006-02-06 Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält

Country Status (7)

Country Link
US (1) US8530192B2 (de)
EP (1) EP1851305B1 (de)
JP (2) JP5523674B2 (de)
CN (1) CN101120085B (de)
AT (1) ATE541919T1 (de)
ES (1) ES2380485T3 (de)
WO (1) WO2006084826A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
MX353340B (es) 2006-09-13 2018-01-09 Abbvie Inc Mejoras de cultivos celulares.
CA2668771C (en) 2006-11-08 2016-03-15 Wyeth Rationally designed media for cell culture
CA2709890A1 (en) * 2007-12-27 2009-07-09 Andre Giovagnoli Cell culture processes
TW201024318A (en) 2008-10-20 2010-07-01 Abbott Lab Isolation and purification of antibodies using protein A affinity chromatography
SG195577A1 (en) 2008-10-20 2013-12-30 Abbott Lab Viral inactivation during purification of antibodies
HUE026210T2 (en) * 2008-11-12 2016-05-30 Baxalta Inc Procedure for serum-free, insulin-free VII. factor
FR2948381B1 (fr) * 2009-07-24 2013-07-12 Oncobiotek Procede d'obtention de myofibroblastes.
US9629888B2 (en) * 2010-03-05 2017-04-25 Leafpro, Llc Composition of matter for delivering lipid-soluble materials, and a method for producing it
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
KR20150043523A (ko) 2012-09-02 2015-04-22 애브비 인코포레이티드 단백질 불균일성의 제어 방법
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
AR095348A1 (es) * 2013-03-15 2015-10-07 Genentech Inc Medios de cultivo celular y métodos de producción de anticuerpos
EP3052640A2 (de) 2013-10-04 2016-08-10 AbbVie Inc. Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN108624549B (zh) * 2017-03-23 2020-11-20 上海奥浦迈生物科技有限公司 一种cho dg44培养基及其应用
KR102609289B1 (ko) * 2018-12-06 2023-12-01 인벤트프라이즈 인크. 비-동물성 배지에서의 박테리아 증식
US10961500B1 (en) * 2019-04-23 2021-03-30 Regeneron Pharmaceuticals, Inc. Cell culture medium for eukaryotic cells
RU2741088C1 (ru) * 2019-12-30 2021-01-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Композиция на основе гидролизата белка гороха для повышения специфической продуктивности клеточных линий продуцентов и способ её получения
RU2741086C1 (ru) * 2019-12-31 2021-01-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Композиция на основе гидролизата белка подсолнечника для повышения специфической продуктивности клеточных линий продуцентов и способ её получения
PL4043551T3 (pl) * 2021-02-12 2025-04-07 Bühler AG Podłoża do hodowli komórkowych zawierające hydrolizaty białek roślinnych

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
ATE330003T1 (de) * 1999-08-05 2006-07-15 Baxter Ag Rekombinanter stabiler zellklon, seine herstellung und verwendung
US7572619B2 (en) * 2000-03-22 2009-08-11 Octagene Gmbh Recombinant blood clotting factors
EP1325127B1 (de) 2000-10-02 2009-03-11 Novo Nordisk Health Care AG Verfahren zur herstellung vitamin-k-abhängiger proteine
HUP0402158A2 (hu) * 2001-10-02 2005-01-28 Novo Nordisk Health Care Ag Rekombináns fehérjék előállítási eljárása eukarióta sejtekben

Also Published As

Publication number Publication date
JP2008529511A (ja) 2008-08-07
EP1851305A1 (de) 2007-11-07
EP1851305B1 (de) 2012-01-18
US20080254514A1 (en) 2008-10-16
JP5523674B2 (ja) 2014-06-18
ES2380485T3 (es) 2012-05-14
US8530192B2 (en) 2013-09-10
CN101120085A (zh) 2008-02-06
WO2006084826A1 (en) 2006-08-17
JP2014110794A (ja) 2014-06-19
CN101120085B (zh) 2011-06-08

Similar Documents

Publication Publication Date Title
WO2003089567A3 (en) Apparatus and method for a cell culture in a bioreactor at high cell concentration
Ma et al. Non-small molecule PROTACs (NSM-PROTACs): protein degradation kaleidoscope
RU2009132986A (ru) Применение меди и глутамата в культуре клеток для производства полипептидов
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
ATE331025T2 (de) Medium für die protein- und serumfreie zellkultur
DK1483369T3 (da) Fuglecellelinier til fremstiling af stoffer af interesse
WO2002101019A3 (en) Methods of culturing animal cells and polypeptide production in animal cells
ATE415812T1 (de) Stress-gekoppelte kalium kanal proteine sowie methoden zu deren verwendung in pflanzen
ZA200703124B (en) System and method for production of antibodies in plant cell culture
DE60138127D1 (de) Stoffwechseländerungen in gärungen zur produktion rekombinanter proteine
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
CY1110267T1 (el) Μεθοδος για την καλλιεργεια κυτταρων για την παραγωγη ουσιων
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
DK0474790T3 (da) Medier til cellevækst og fremgangsmåde til fremstilling deraf
MX2020009907A (es) Glicoformas afucosiladas totales de anticuerpos producidos en cultivo celular.
DE60307615D1 (de) Zellkulturmedium
WO2004053137A3 (en) Method for protein production
GB2429211A (en) Feeder independent extended culture of embryonic stem cells
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
WO2006060769A3 (en) Methods and materials for expression of a recombinant protein
FI3063287T3 (fi) Monensiinin käyttö rekombinanttiproteiinien glykosylaation säätelyyn
Chai et al. Effect of bubble velocity and pH step changes on the foam fractionation of sporamin
DK1861504T3 (da) Glycoengineering i svampe
ATE541920T1 (de) Mit stress verbundene proteinphosphatase- polypeptide und verfahren zur verwendung in pflanzen
Franěk Gluten of spelt wheat (Triticum aestivum subspecies spelta) as a source of peptides promoting viability and product yield of mouse hybridoma cell cultures